Does an FDA Letter of Guaranty Actually Protect You?

An FDA Letter of Guaranty only shields you from penalties if the person who signs it resides in the United States. That is the explicit requirement of 21 USC 333(c)(2). A guaranty signed by your Chinese supplier gives you zero protection from FDA penalties — but a US-resident agent of that same supplier can sign a valid one. The defect is the signer's residency, not the product's origin.

Last verified June 14, 2026 against 21 USC 333 and 21 USC 331 (Cornell LII), FDA Compliance Policy Guide 110.500, and 21 CFR 7.12–7.13. CertDesk re-verifies this page quarterly.

Importers of food-contact goods collect a Letter of Guaranty from the factory and file it as proof of protection. For a guaranty signed only overseas, that protection does not exist — and the reason is a single phrase in the statute that most suppliers, and many importers, have never read closely.

A guaranty is a penalty defense, nothing more and nothing less. The Federal Food, Drug, and Cosmetic Act prohibits introducing an adulterated or misbranded article into commerce (section 301 of the Act, codified at 21 USC 331). The penalty provisions sit in section 303 (21 USC 333). Within them, subsection (c)(2) gives a buyer a defense — if, and only if, the guaranty meets specific conditions:

"No person shall be subject to the penalties of subsection (a)(1) … (2) for having violated section 331(a) or (d) of this title, if he establishes a guaranty or undertaking signed by, and containing the name and address of, the person residing in the United States from whom he received in good faith the article …" — 21 USC 333(c)(2)

The operative words are "the person residing in the United States." The defense is built around the signer's residency. A guaranty is the mechanism by which liability moves up the chain to a party FDA can actually reach — and FDA can only reach a US resident. That is the whole architecture of the provision.

Because your Chinese supplier does not reside in the United States, and the statute makes residency the condition. FDA's own Compliance Policy Guide is blunt about it:

"It is thus apparent from the law itself that the guarantor must be a U.S. resident to comply with the act." — FDA Compliance Policy Guide Sec. 110.500

So the document that importers most often treat as their shield — a guaranty on factory letterhead, signed in Shenzhen or Ningbo — provides no section 333(c)(2) defense at all. It is not that the document is fraudulent or that the goods are necessarily non-compliant. It is that the law will not accept a non-resident as a guarantor. When FDA comes looking for someone to hold accountable, an overseas signature points at a party outside its penalty reach, so the defense collapses back onto you, the importer.

This is the trap: the guaranty looks like protection, files like protection, and is produced precisely to feel like protection — while doing nothing the importer is counting on it to do.

Yes — and this is the nuance that separates a correct understanding from an alarmist one. The defect is the signer's residency, not the fact that the product was imported. The same Compliance Policy Guide says so directly:

"The domestic agent of the foreign manufacturer, if he resides in the U.S., could provide such a guaranty." — FDA Compliance Policy Guide Sec. 110.500

So a valid guaranty on imported goods is entirely possible. If a US-resident party in your supply chain — a domestic agent of the foreign manufacturer, a US-based importer or distributor, or the manufacturer's US subsidiary — signs the guaranty and puts its US name and address on it, the section 333(c)(2) defense can attach. What cannot work is a guaranty whose only signer is the overseas factory. "You can never have a valid guaranty on an import" is wrong; "your Chinese supplier's signature cannot carry the FDA penalty defense" is right. The fix is to obtain the guaranty from a US-resident counterparty, not to abandon guaranties altogether.

Importers often conflate these two documents, but they answer different questions and a careful program uses both.

FDA's regulations even provide suggested guaranty language — a limited form and a general or continuing form — at 21 CFR 7.12 and 7.13, and both require the signer's name and post-office address. But a properly formatted guaranty with an overseas signature is still a non-resident guaranty. The format is not the problem; the residency is. And a guaranty, however signed, never substitutes for evidence that the material meets the applicable food-contact clearance in 21 CFR Parts 174 to 178 — that is the Declaration of Compliance's job.

Three things, in combination, are what a defensible food-contact program rests on:

1. A guaranty from a US-resident party in your chain. This is the only thing that delivers the actual section 333(c)(2) penalty defense. If no US resident will sign it, you have no statutory defense — and that absence is itself information about how much your counterparty stands behind the goods.
2. Your own testing and diligence against the 21 CFR clearance. The material has to actually meet the conditions of the applicable food-contact rule. Verifying that is material work — confirming the resin identity and that any additives sit within their cleared uses — not a matter of collecting signatures.
3. A data-backed Declaration of Compliance. A DoC that cites the specific clearance and the evidence behind it is worth far more than a guaranty with nothing under it. It is the document that connects the regulation to your actual material.

The through-line is that protection comes from evidence about the material plus a counterparty FDA can reach — not from a piece of paper whose signer sits outside US jurisdiction.

Yes, provided you file it under the right heading. A guaranty from your Chinese supplier is a contract. It gives you indemnity and recourse you can pursue against the supplier, a documented good-faith diligence trail that shows you asked the right questions, and traceability back to the maker if something goes wrong. Those are real and worth having. What it is not is FDA immunity. The cleanest way to hold both truths at once: a guaranty from your Chinese supplier is a contract you can sue on, not a shield you can hide behind.

And it does not affect admissibility either way. FDA can detain or refuse a food-contact shipment at the border whenever the material fails to meet the applicable 21 CFR requirement, regardless of any guaranty on file. A guaranty is a penalty defense, never an import pass — one more reason it cannot stand in for verifying the material itself.

If your compliance rests on a food-contact claim, the next step is to confirm the claim is backed by evidence and that the material matches it. See material compliance verification for the full framework, how to verify a supplier's test report for checking the documents, or map which rules apply to your products with the free Deadline Checker.

Does a Letter of Guaranty from my Chinese supplier protect me from FDA penalties?

No. The penalty defense under 21 USC 333(c)(2) only applies to a guaranty signed by a person residing in the United States. A guaranty signed by a foreign supplier — your factory in China — gives you zero protection from FDA penalties under section 303, because the signer is not a US resident. The defect is the signer's residency, not the product's origin.

Can an importer ever have a valid FDA guaranty on imported goods?

Yes. Per FDA Compliance Policy Guide 110.500, a US-resident domestic agent of the foreign manufacturer can sign a valid guaranty. The requirement is that the guarantor reside in the United States — not that the goods be made there. So a guaranty from a US-based agent, importer, or distributor in your chain can carry the section 333(c)(2) defense, while one signed only by the overseas factory cannot.

What is the difference between a Letter of Guaranty and a Declaration of Compliance?

They answer different questions. A Letter of Guaranty answers 'who will FDA hold accountable?' — and it only works if a US resident signs it. A Declaration of Compliance answers 'is the material actually compliant, and on what evidence?' In the US a Declaration of Compliance is voluntary (it is mandatory in the EU). A careful importer wants both, from a US-resident counterparty, backed by data.

If the guaranty is worthless, does FDA still let the goods in?

The guaranty and admissibility are separate. FDA can detain or refuse a food-contact shipment at the border regardless of any guaranty, if the material does not meet the applicable 21 CFR requirement. A guaranty is a penalty defense, not an import pass — which is another reason it cannot substitute for actually verifying the material.

Does a Chinese supplier's guaranty have any value at all?

Yes, just not as FDA immunity. A guaranty from your Chinese supplier is a contract — it gives you indemnity and recourse you can pursue, a documented good-faith diligence trail, and traceability back to the maker. Treat it as a contract you can sue on, not a shield you can hide behind. The FDA penalty defense still requires a US-resident signer.